ENDOSCOPIC TREATMENT OF ESOPHAGEAL-BRONCHIAL FISTULA IN A PATIENT WITH A LEYDEN MUTATION
DOI:
https://doi.org/10.31618/ESSA.2782-1994.2021.1.69.41Keywords:
endoscopy, bronchoscopy, esophagoscopy, Factor V Leiden, Bronchoesophageal fistula, fistula, bronchus, esophagus.Abstract
Bronchoesophageal Fistula (BEF) is an uncommon condition related to complex thoracic surgery. The development of BEF is usually an indication of the progression of bronchial or lung cancer; whereas the etiology of this illness being recorded as benign is much rarer – not exceeding 4 - 6%. [1, 2].
Surgery is the main method for treating patients who have benign BEF, allowing for the reliable result. At the same time, similar operations are extremely traumatic and are fraught with the development of post-operation complications, especially when concerning patients with genetically determined coagulopathy.
Factor V Leiden mutation is a hereditary coagulopathy in which there is a point mutation in the gene that encodes blood coagulation factor V. Factor V Leiden mutation is the most common cause of the hereditary disposition to thrombosis, heart attacks, strokes in Europeans. The frequency of occurence among the population of the USA is 4 – 6% [3].
We present our own observation of successful endoscopic surgery to treat BEF in a patient with Factor V Leiden mutation and chronic pulmonary embolism.
References
De Giacomo T, Franconi F, Venuta F et al. Benign esophageal-respiratory fistulae. The surgical treatment and results of 10 cases. Minerva Chir 1993;48(7):311-316.
Kaul DR, Orringer MB, Saint S, Jones SR. The drenched doctor — a 55-year-old male physician was seen in August because of a 1-week history of fever and night sweats. N Engl J Med 2007;356(18):1871–1876. https://doi.org/10.1056/NEJMcps065377
Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997;127(10):895-903. https://doi.org/10.7326/0003-4819-127-10-199711150-00007
Albucher JF, Guiraud-Chaumeil B, Choller F et al. Frequency of resistance to activated protein С due to factor V mutation in young patients with ischemic stroke. Stroke 1996;27(4):766-767.
Ahn JY, Jung HY, Choi JY et al. Benign bronchoesophageal fistula in adults: endoscopic closure as primary treatment. Gut Liver 2010;4(4):508513. https://doi.org/10.5009/gnl.2010.4.4.508
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
